How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

News 12 is taking you to “The East End.” Join us as we explore the popular Long Island region where foodies, families and outdoor enthusiasts can all find the perfect nearby getaway. Find out where ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Meta to track employee keystrokes, screen activity to train AI agents The data, gathered through a new internal tool, will be used to improve AI agents’ ability to navigate software and complete ...